Global In Vitro Organ Preservation 麻豆原创 Research Report 2023

Publication ID:

PB503235483

Publication Date:

March 10, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Highlights
The global In Vitro Organ Preservation market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for In Vitro Organ Preservation is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for In Vitro Organ Preservation is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for In Vitro Organ Preservation in Kidneys is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of In Vitro Organ Preservation include Xvivo Perfusion, Paragonix Technologies, Dr. Franz K枚hler Chemie GMBH, Essential Pharmaceuticals, Transmedics, Organox Limited, Shanghai Genext Medical Technology, Waters Medical Systems and Transplant Biomedicals, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for In Vitro Organ Preservation, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding In Vitro Organ Preservation.
The In Vitro Organ Preservation market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global In Vitro Organ Preservation market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the In Vitro Organ Preservation companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Xvivo Perfusion
Paragonix Technologies
Dr. Franz K枚hler Chemie GMBH
Essential Pharmaceuticals
Transmedics
Organox Limited
Shanghai Genext Medical Technology
Waters Medical Systems
Transplant Biomedicals
Segment by Type
Static Cold Storage
Hypothermic Machine Perfusion
Normothermic Machine Perfusion
Segment by Application
Kidneys
Liver
Lung
Heart
Others (Intestine & Pancreas)
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of In Vitro Organ Preservation companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global In Vitro Organ Preservation 麻豆原创 Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Static Cold Storage
1.2.3 Hypothermic Machine Perfusion
1.2.4 Normothermic Machine Perfusion
1.3 麻豆原创 by Application
1.3.1 Global In Vitro Organ Preservation 麻豆原创 Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Kidneys
1.3.3 Liver
1.3.4 Lung
1.3.5 Heart
1.3.6 Others (Intestine & Pancreas)
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global In Vitro Organ Preservation 麻豆原创 Perspective (2018-2029)
2.2 In Vitro Organ Preservation Growth Trends by Region
2.2.1 Global In Vitro Organ Preservation 麻豆原创 Size by Region: 2018 VS 2022 VS 2029
2.2.2 In Vitro Organ Preservation Historic 麻豆原创 Size by Region (2018-2023)
2.2.3 In Vitro Organ Preservation Forecasted 麻豆原创 Size by Region (2024-2029)
2.3 In Vitro Organ Preservation 麻豆原创 Dynamics
2.3.1 In Vitro Organ Preservation Industry Trends
2.3.2 In Vitro Organ Preservation 麻豆原创 Drivers
2.3.3 In Vitro Organ Preservation 麻豆原创 Challenges
2.3.4 In Vitro Organ Preservation 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top In Vitro Organ Preservation Players by Revenue
3.1.1 Global Top In Vitro Organ Preservation Players by Revenue (2018-2023)
3.1.2 Global In Vitro Organ Preservation Revenue 麻豆原创 Share by Players (2018-2023)
3.2 Global In Vitro Organ Preservation 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by In Vitro Organ Preservation Revenue
3.4 Global In Vitro Organ Preservation 麻豆原创 Concentration Ratio
3.4.1 Global In Vitro Organ Preservation 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by In Vitro Organ Preservation Revenue in 2022
3.5 In Vitro Organ Preservation Key Players Head office and Area Served
3.6 Key Players In Vitro Organ Preservation Product Solution and Service
3.7 Date of Enter into In Vitro Organ Preservation 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 In Vitro Organ Preservation Breakdown Data by Type
4.1 Global In Vitro Organ Preservation Historic 麻豆原创 Size by Type (2018-2023)
4.2 Global In Vitro Organ Preservation Forecasted 麻豆原创 Size by Type (2024-2029)
5 In Vitro Organ Preservation Breakdown Data by Application
5.1 Global In Vitro Organ Preservation Historic 麻豆原创 Size by Application (2018-2023)
5.2 Global In Vitro Organ Preservation Forecasted 麻豆原创 Size by Application (2024-2029)
6 North America
6.1 North America In Vitro Organ Preservation 麻豆原创 Size (2018-2029)
6.2 North America In Vitro Organ Preservation 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America In Vitro Organ Preservation 麻豆原创 Size by Country (2018-2023)
6.4 North America In Vitro Organ Preservation 麻豆原创 Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe In Vitro Organ Preservation 麻豆原创 Size (2018-2029)
7.2 Europe In Vitro Organ Preservation 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe In Vitro Organ Preservation 麻豆原创 Size by Country (2018-2023)
7.4 Europe In Vitro Organ Preservation 麻豆原创 Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific In Vitro Organ Preservation 麻豆原创 Size (2018-2029)
8.2 Asia-Pacific In Vitro Organ Preservation 麻豆原创 Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific In Vitro Organ Preservation 麻豆原创 Size by Region (2018-2023)
8.4 Asia-Pacific In Vitro Organ Preservation 麻豆原创 Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America In Vitro Organ Preservation 麻豆原创 Size (2018-2029)
9.2 Latin America In Vitro Organ Preservation 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America In Vitro Organ Preservation 麻豆原创 Size by Country (2018-2023)
9.4 Latin America In Vitro Organ Preservation 麻豆原创 Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa In Vitro Organ Preservation 麻豆原创 Size (2018-2029)
10.2 Middle East & Africa In Vitro Organ Preservation 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa In Vitro Organ Preservation 麻豆原创 Size by Country (2018-2023)
10.4 Middle East & Africa In Vitro Organ Preservation 麻豆原创 Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Xvivo Perfusion
11.1.1 Xvivo Perfusion Company Detail
11.1.2 Xvivo Perfusion Business Overview
11.1.3 Xvivo Perfusion In Vitro Organ Preservation Introduction
11.1.4 Xvivo Perfusion Revenue in In Vitro Organ Preservation Business (2018-2023)
11.1.5 Xvivo Perfusion Recent Development
11.2 Paragonix Technologies
11.2.1 Paragonix Technologies Company Detail
11.2.2 Paragonix Technologies Business Overview
11.2.3 Paragonix Technologies In Vitro Organ Preservation Introduction
11.2.4 Paragonix Technologies Revenue in In Vitro Organ Preservation Business (2018-2023)
11.2.5 Paragonix Technologies Recent Development
11.3 Dr. Franz K枚hler Chemie GMBH
11.3.1 Dr. Franz K枚hler Chemie GMBH Company Detail
11.3.2 Dr. Franz K枚hler Chemie GMBH Business Overview
11.3.3 Dr. Franz K枚hler Chemie GMBH In Vitro Organ Preservation Introduction
11.3.4 Dr. Franz K枚hler Chemie GMBH Revenue in In Vitro Organ Preservation Business (2018-2023)
11.3.5 Dr. Franz K枚hler Chemie GMBH Recent Development
11.4 Essential Pharmaceuticals
11.4.1 Essential Pharmaceuticals Company Detail
11.4.2 Essential Pharmaceuticals Business Overview
11.4.3 Essential Pharmaceuticals In Vitro Organ Preservation Introduction
11.4.4 Essential Pharmaceuticals Revenue in In Vitro Organ Preservation Business (2018-2023)
11.4.5 Essential Pharmaceuticals Recent Development
11.5 Transmedics
11.5.1 Transmedics Company Detail
11.5.2 Transmedics Business Overview
11.5.3 Transmedics In Vitro Organ Preservation Introduction
11.5.4 Transmedics Revenue in In Vitro Organ Preservation Business (2018-2023)
11.5.5 Transmedics Recent Development
11.6 Organox Limited
11.6.1 Organox Limited Company Detail
11.6.2 Organox Limited Business Overview
11.6.3 Organox Limited In Vitro Organ Preservation Introduction
11.6.4 Organox Limited Revenue in In Vitro Organ Preservation Business (2018-2023)
11.6.5 Organox Limited Recent Development
11.7 Shanghai Genext Medical Technology
11.7.1 Shanghai Genext Medical Technology Company Detail
11.7.2 Shanghai Genext Medical Technology Business Overview
11.7.3 Shanghai Genext Medical Technology In Vitro Organ Preservation Introduction
11.7.4 Shanghai Genext Medical Technology Revenue in In Vitro Organ Preservation Business (2018-2023)
11.7.5 Shanghai Genext Medical Technology Recent Development
11.8 Waters Medical Systems
11.8.1 Waters Medical Systems Company Detail
11.8.2 Waters Medical Systems Business Overview
11.8.3 Waters Medical Systems In Vitro Organ Preservation Introduction
11.8.4 Waters Medical Systems Revenue in In Vitro Organ Preservation Business (2018-2023)
11.8.5 Waters Medical Systems Recent Development
11.9 Transplant Biomedicals
11.9.1 Transplant Biomedicals Company Detail
11.9.2 Transplant Biomedicals Business Overview
11.9.3 Transplant Biomedicals In Vitro Organ Preservation Introduction
11.9.4 Transplant Biomedicals Revenue in In Vitro Organ Preservation Business (2018-2023)
11.9.5 Transplant Biomedicals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Xvivo Perfusion
Paragonix Technologies
Dr. Franz K枚hler Chemie GMBH
Essential Pharmaceuticals
Transmedics
Organox Limited
Shanghai Genext Medical Technology
Waters Medical Systems
Transplant Biomedicals

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.